These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25026276)

  • 1. Dietary energy balance modulates ovarian cancer progression and metastasis.
    Al-Wahab Z; Tebbe C; Chhina J; Dar SA; Morris RT; Ali-Fehmi R; Giri S; Munkarah AR; Rattan R
    Oncotarget; 2014 Aug; 5(15):6063-75. PubMed ID: 25026276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.
    Al-Wahab Z; Mert I; Tebbe C; Chhina J; Hijaz M; Morris RT; Ali-Fehmi R; Giri S; Munkarah AR; Rattan R
    Oncotarget; 2015 May; 6(13):10908-23. PubMed ID: 25895126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells.
    Liu L; Wang X; Li X; Wu X; Tang M; Wang X
    Oncol Rep; 2018 Feb; 39(2):818-826. PubMed ID: 29251331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and evaluation of pre-clinical suitability of a syngeneic orthotopic mouse ovarian cancer model.
    Cho S; Sun Y; Soisson AP; Dodson MK; Peterson CM; Jarboe EA; Kennedy AM; Janát-Amsbury MM
    Anticancer Res; 2013 Apr; 33(4):1317-24. PubMed ID: 23564768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis.
    Wei X; Liu Y; Gong C; Ji T; Zhou X; Zhang T; Wan D; Xu S; Jin P; Yang X; Li X; Ma D; Yang Z; Gao Q
    Anticancer Agents Med Chem; 2017; 17(8):1093-1101. PubMed ID: 28002999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis.
    He L; He J; Zhao X
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e161-6. PubMed ID: 23915006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
    Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
    Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis.
    Vera C; Tapia V; Vega M; Romero C
    J Ovarian Res; 2014 Aug; 7():82. PubMed ID: 25296882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early inflammatory response in epithelial ovarian tumor cyst fluids.
    Kristjánsdóttir B; Partheen K; Fung ET; Yip C; Levan K; Sundfeldt K
    Cancer Med; 2014 Oct; 3(5):1302-12. PubMed ID: 24947406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism.
    Ma Z; Zhang T; Wang R; Cheng Z; Xu H; Li W; Wang Y; Wang X
    Int J Gynecol Cancer; 2011 May; 21(4):616-24. PubMed ID: 21543928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrillar type I collagen matrices enhance metastasis/invasion of ovarian epithelial cancer via β1 integrin and PTEN signals.
    Shen Y; Shen R; Ge L; Zhu Q; Li F
    Int J Gynecol Cancer; 2012 Oct; 22(8):1316-24. PubMed ID: 23013730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels.
    Alsina-Sanchis E; Figueras A; Lahiguera Á; Vidal A; Casanovas O; Graupera M; Villanueva A; Viñals F
    Int J Cancer; 2016 Oct; 139(8):1894-903. PubMed ID: 27299695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
    Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
    Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.
    Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K
    Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells.
    Hu Z; Cai M; Deng L; Zhu L; Gao J; Tan M; Liu J; Lin B
    Oncotarget; 2016 Dec; 7(50):82921-82932. PubMed ID: 27863372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.
    Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R
    Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
    Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
    Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.
    Decio A; Taraboletti G; Patton V; Alzani R; Perego P; Fruscio R; Jürgensmeier JM; Giavazzi R; Belotti D
    Am J Pathol; 2014 Apr; 184(4):1050-1061. PubMed ID: 24508126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
    Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
    Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.